High plasma fetuin-A levels are associated with metabolic syndrome among males but not females in a Japanese general population

Diabetes Research and Clinical Practice

Volumn 106, Issue 1, 2014, Pages 128-135

  Obuchi, Aya ^a   Adachi, Hisashi ^a   Enomoto, Mika ^a   Fukami, Ako ^a   Kumagai, Eita ^a   Nakamura, Sachiko ^a   Yoshimura, Ayako ^a   Nohara, Yume ^a   Nakao, Erika ^a   Umeki, Yoko ^a   Fukumoto, Yoshihiro ^a   Imaizumi, Tsutomu ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Epidemiology; Fetuin A; General population; Metabolic syndrome

Indexed keywords

FETUIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; AHSG PROTEIN, HUMAN; ALPHA FETOPROTEIN; BIOLOGICAL MARKER; INSULIN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMMUNITY SAMPLE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH SURVEY; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; JAPAN; METABOLISM; MIDDLE AGED; PREVALENCE; RISK;

ADULT; AGED; ALPHA-2-HS-GLYCOPROTEIN; ALPHA-FETOPROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; SEX FACTORS;

EID: 84908054174     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.07.002     Document Type: Article

References (43)

1. Ketteler M., Bongartz P., Westenfeld R., Wildberger J.E., Mahnken A.H., Böhm R., et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003, 361:827-833.
2. Schinke T., Amendt C., Trindl A., Pöschke O., Müller-Esterl W., Jahnen-Dechent W. The serum protein a2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. J Biol Chem 1996, 271:20789-20796.
3. Jahnen-Dechent W., Schinke T., Trindl A., Müller-Esterl W., Sablitzky F., Kaiseri S., et al. Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 1997, 272:31496-31503.
4. Szweras M., Liu D., Partridge E.A., Pawling J., Sukhu B., Clokie C., et al. α2-HS glycoprotein/fetuin, a transforming growth factor-β/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 2002, 277:19991-19997.
5. Mathews S.T., Singh G.P., Ranalletta M., Cintron V.J., Qiang X., Goustin A.S., et al. Improved insulin sensitivity and resistance to weight gain in mice null for the AHSG gene. Diabetes 2002, 51:2450-2458.
6. Ou H.Y., Wu H.T., Hung H.C., Yang Y.C., Wu J.S., Chang C.J. Multiple mechanisms of GW-9508, a selective G protein-coupled receptor 40 agonist, in the regulation of glucose homeostasis and insulin sensitivity. Am J Physiol Endocrinol Metab 2013, 67:E668-E676.
7. Stefan N., Hennige A., Staiger H., Machann J., Schick F., Kröber S., et al. α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006, 29:853-857.
8. Ix J.H., Shlipak M.G., Brandenburg V.M., Ali S., Ketteler M., Whooley M.A. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006, 113:1760-1767.
9. Fisher E., Stefan N., Saar K., Drogan D., Schulze M.B., Fritsche A., et al. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam Study. Circ Cardiovasc Genet 2009, 2:607-613.
10. Ix J.H., Katz R., de Boer I.H., Kestenbaum B.R., Peralta C.A., Jenny N.S., et al. Fetuin-A is inversely associated with coronary artery calcification in community-living persons: the Multi-Ethnic Study of Atherosclerosis. Clin Chem 2012, 58:887-895.
11. Dogru T., Genc H., Tapan S., Aslan F., Ercin C.N., Ors F., et al. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. Clin Endocrinol 2013, 78:712-717.
12. Xu Y., Xu M., Bi Y., Song A., Huang Y., Liu Y., et al. Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese. Atherosclerosis 2011, 216:180-186.
13. Song A., Xu M., Bi Y., Xu Y., Huang Y., Li M., et al. Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults. PLoS ONE 2011, 6:e19228.
14. Jung C.H., Kim B.Y., Kim C.H., Kang S.K., Jung S.H., Mok J.O. Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes. Diab Vasc Dis Res 2013, 10:459-467.
15. Laughlin G.A., Barrett-Connor E., Cummins K.M., Daniels L.B., Wassel C.L., Ix J.H. Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults. Diabetes Care 2013, 36:1994-2000.
16. Ismail N.A., Ragab S., Abd El Dayem S.M., Abd ElBaky A., Salah N., Hamed M., et al. Fetuin-A levels in obesity: differences in relation to metabolic syndrome and correlation with clinical and laboratory variables. Arch Med Sci 2012, 5:826-833.
17. Rasul S., Wagner L., Kautzky-Willer A. Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus. Endocrine 2012, 42:496-505.
18. Ix J.H., Biggs M.L., Mukamal K.J., Kizer J.R., Zieman S.J., Siscovick D.S., et al. Association of fetuin-A with incident diabetes mellitus in community-living older adults: the Cardiovascular Health Study. Circulation 2012, 25:2316-2322.
19. Singh M., Sharma P.K., Garg V.K., Mondal S.C., Singh A.K., Kumar N. Role of fetuin-A in atherosclerosis associated with diabetic patients. J Pharm Pharmacol 2012, 64:1703-1708.
20. Jensen M.K., Bartz T.M., Mukamal K.J., Djousse L., Kizer J.R., Tracy R.P., et al. Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults. Diabetes Care 2013, 36:1222-1228.
21. Stefan N., Fritsche A., Weikert C., Boeing H., Joost H.G., Häring H.U., et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008, 57:2762-2767.
22. Ix J.H., Wassel C.L., Kanaya A.M., Vittinghoff E., Johnson K.C., Koster A., et al. Fetuin-A and incident diabetes mellitus in older persons. J Am Med Assoc 2008, 300:182-188.
23. Weikert C., Stefan N., Schulze M.B., Pischon T., Berger K., Joost H.G., et al. Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008, 118:2555-2562.
24. Lim P., Collet J.P., Moutereau S., Guigui N., Mitchell-Heggs L., Loric S., et al. Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction. Clin Chem 2007, 53:1835-1840.
25. Roos M., von Eynatten M., Heemann U., Rothenbacher D., Brenner H., Breitling L.P. Serum fetuin-A cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease. Am J Cardiol 2010, 105:1666-1672.
26. Ix J.H., Barrett-Connor E., Wassel C.L., Cummins K., Bergstrom J., Daniels L.B., et al. The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study. J Am Coll Cardiol 2011, 58:2372-2379.
27. Laughlin G.A., Cummins K.M., Wassel C.L., Daniels L.B., Ix J.H. The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo Study. J Am Coll Cardiol 2012, 59:1688-1696.
28. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992. on behalf of the collaborators developing the Japanese equation for estimated GFR.
29. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
30. Third Report of the National Cholesterol Educational Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 2002, 106:3143-3421.
31. Matsuzawa Y. Metabolic syndrome - definition and diagnostic criteria in Japan. J Atheroscler Thromb 2005, 12:301.
32. Iso H., Kitamura A., Shimamoto T., Sankai T., Naito Y., Sato S., et al. Alcohol intake and the risk of cardiovascular disease in middle-aged Japanese men. Stroke 1995, 26:767-773.
33. Mori K., Emoto M., Yokoyama H., Araki T., Teramura M., Koyama H., et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 2006, 29:468. [Letter to editor].
34. Ishibashi A., Ikeda Y., Ohguro T., Kumon Y., Yamanaka S., Takata H., et al. Serum fetuin-A is an independent marker of insulin resistance in Japanese men. J Atheroscler Thromb 2010, 17:925-933.
35. Menotti A., Blackburn H., Kromhout D., Nissinen A., Fidanza F., Giampaoli S., et al. Changes in population cholesterol levels and coronary heart disease deaths in seven countries. Eur Heart J 1997, 18:566-571.
36. Lorant D.P., Grujicic M., Hoebaus C., Brix J.M., Hoellerl F., Schernthaner G., et al. Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease. Diabetes Care 2011, 34:156-161.
37. Tong P.C., Lee K.F., So W.Y., Ng M.H., Chan W.B., Lo M.K., et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 2004, 27:216-222.
38. Nakanishi S., Yamane K., Kamei N., Okubo M., Kohno N. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 2003, 26:2754-2757.
39. Matsumoto K., Sera Y., Abe Y., Ueki Y., Tominaga T., Miyake S. Inflammation and insulin resistance are independently related to all cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. Atherosclerosis 2003, 169:317-321.
40. Marfella R., Esposito K., Nappo F., Siniscalchi M., Sasso F.C., Portoghese M., et al. Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes 2004, 53:2383-2391.
41. Joosten M.M., Schrieks I.C., Hendriks H.F.J. Effect of moderate alcohol consumption on fetuin-A levels in men and women: post-hoc analyses of three open-label randomized crossover trials. Diabetol Metab Syndr 2014, 18(6):24.
42. Ley S.H., Sun Q., Jimenez M.C., Rexrode K.M., Manson J.E., Jensen M.K., et al. Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women. Diabetologia 2014, 57:93-101.
43. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-1131.